Mitotic inhibitors
A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.
| Drug Name |
Reviews | Avg. Ratings |
|
|---|---|---|---|
| vincristine systemic (Pro, More...) |
0 Review(s) | Rate It! | 7.0 |
| etoposide systemic (Pro, More...) |
0 Review(s) | Rate It! | 6.0 |
| docetaxel systemic (Pro, More...) |
0 Review(s) | Not rated - Be the first | |
| ixabepilone systemic (Pro, More...) |
0 Review(s) | Not rated - Be the first | |
| paclitaxel protein-bound systemic (More...) |
0 Review(s) | Not rated - Be the first | |
| paclitaxel systemic (Pro, More...) |
0 Review(s) | Not rated - Be the first | |
| teniposide systemic (Pro, More...) |
0 Review(s) | Not rated - Be the first | |
| vinblastine systemic (Pro, More...) |
0 Review(s) | Not rated - Be the first | |
| vinorelbine systemic (Pro, More...) |
0 Review(s) | Not rated - Be the first | |
See also
Medical Conditions associated with mitotic inhibitors:
- Acute Lymphoblastic Leukemia
- Acute Lymphocytic Leukemia
- Acute Myeloid Leukemia
- Anaplastic Oligodendroglioma
- Breast Cancer
- Breast Cancer, Adjuvant
- Breast Cancer, Metastatic
- Cancer
- Choriocarcinoma
- Evan's Syndrome
- Gastric Cancer
- Head and Neck Cancer
- Histiocytosis
- Hodgkin's Lymphoma
- Kaposi's Sarcoma
- Lymphoma
- Multiple Myeloma
- Mycosis Fungoides
- Neuroblastoma
- Non-Hodgkin's Lymphoma
- Non-Small Cell Lung Cancer
- Ovarian Cancer
- Prostate Cancer
- Rhabdomyosarcoma
- Small Cell Lung Cancer
- Testicular Cancer
- Wilms' Tumor

